Twist Bioscience partners with Miroculus on clinical products

By The Science Advisory Board staff writers

February 25, 2020 -- Synthetic biology company Twist Bioscience announced on February 25 that it has initiated a collaboration with digital microfluidics developer Miroculus for target enrichment and sample library preparation kits.

Twist Bioscience will bring its library preparation and target enrichment next-generation sequencing workflows to Miroculus's Miro Canvas system, a novel automation platform. The goal of the partnership is to streamline experimental processes and offer a wide range of clinical solutions.

LabCorp adopts Thermo Fisher NGS for companion diagnostics
LabCorp announced on January 14 that it will adopt Thermo Fisher Scientific's Ion Torrent Genexus next-generation sequencing (NGS) system and Oncomine...
A convergence of technologies, revolutionizing next-generation sequencing
A new, powerful combination of biochips and next-generation sequencing (NGS) is capable of solving unique and important biological problems, such as single-cell,...

Copyright © 2020 scienceboard.net


Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Email
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter